Podium Power Archives - Page 3 of 22

Emilio Torres at IV CONGRESO CÓRNEA COLOMBIA 2025

ELZA at ESCRS 2025 – What to Expect

From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…

ELZA’s CEO, Nikki Hafezi, to Direct New Course at Tashkent’s International Summer School

We are proud to announce that ELZA Institute’s CEO, Nikki L. Hafezi MAS IP ETHZ, will serve as Course Director for a new international program in Uzbekistan — the “Professional Development Course in Visual Sciences and Public Health”.

Prof. Farhad Hafezi Inducted into Academia Ophthalmologica Internationalis

Prof. Farhad Hafezi joins the Academia Ophthalmologica Internationalis at its 50th Anniversary General Assembly in Leiden, June 2025.

From Lisbon to Santander, SOE and SECOP 2025

Dion Paridaens shared updates at SOE and SECOP 2025, highlighting his and ESOPRS’s role in advancing oculoplastics across Europe.

Polish Ophthalmology Congress Highlights with Prof. Hafezi

At the Polish Ophthalmologists Congress, Prof. Farhad Hafezi presented innovative keratoconus treatments ELZA-PACE and ECO-CAIRS in Krakow.

ELZA-PACE Cross-Linking and more at BRASCRS 2025

Dr. Emilio Torres-Netto presented ELZA-PACE cross-linking at BRASCRS 2025, a customised, tissue-preserving keratoconus vision rehabilitation method with promising clinical outcomes.

Innovations in the Biomechanical Management of Advanced Keratoconus at EgSCRS

At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.

Nikki Hafezi Takes Part in ASMI 70th Anniversary Celebration in Uzbekistan

As part of the 70th Anniversary celebration of the Andijan State Medical Institute (ASMI) in Uzbekistan, ELZA Institute CEO, Nikki Hafezi, MAS IP ETHZ, took part in a series of high-level academic and institutional events from April 28 to May 1, 2025.

Nikki Hafezi Challenges the Rare Disease Status of Keratoconus

Hafezi addressed the widespread reliance on a 1986 prevalence estimate that places keratoconus at 1 in 2,000—formally classifying it as rare. Yet as she highlighted, emerging epidemiological data tell a starkly different story. Keratoconus is an orphan disease, not a rare one.

Our Areas of Expertise

Laser Eye Surgery

Dry Eye

Myopia Control

Cornea

Cataract

Orbit

Keratoconus

Glaucoma

Eyelids

Cross-Linking

Retina

How to find us

Your first visit

Your surgery

International patients

Online video consultation

Downloads

Our Areas of Expertise

Laser Eye Surgery

Keratoconus

Cornea

Cataract

Eyelids

Glaucoma

Orbita

Cross-Linking

Dry Eye

Retina

ELZA Dietikon

ELZA HB Zürich

Request Callback

Email Us

Swiss patients:

Recommend Us

International Patients:

Podium Power

Our Areas of Expertise

Downloads

Our Areas of Expertise

ELZA Dietikon

ELZA HB Zürich

Podium Power

Newsletter

Thank you!

Newsletter

Vielen Dank!